🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multi-site, Phase 1/2 clinical trial is an open-label study to identif...
Status
Recruiting
Location
Precision NextGen Oncology
Start Date
2023-11-01
Trial ID
NCT06047379
This study is a prospective, randomized phase III, to evaluate if in patien...
Status
Active Not Recruiting
Location
Ospedale San Salvatore
Start Date
2021-04-30
Trial ID
NCT04776655
Treatments Being Tested
This is a Phase I/II, single-arm, open-label, multi-center study to evaluat...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2026-08-12
Trial ID
NCT07790510
This open-label, prospective, single-arm, multicenter study will evaluate t...
Status
Completed
Location
Canberra Hospital
Start Date
2012-06-26
Trial ID
NCT01588990
Treatments Being Tested
This is an open-label, multicenter, randomized, Phase 3 study in patients w...
Status
Completed
Location
Arizona Cancer Center
Start Date
2018-09-15
Trial ID
NCT03665441
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Completed
Location
Institut Bergonie
Start Date
2007-01-23
Trial ID
NCT00467142
Treatments Being Tested
Approximately 20-50% of patients with colorectal cancer (CRC) develop dista...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2026-05-10
Trial ID
NCT07604909
Treatments Being Tested
This study is designed to compare the efficacy and safety of two-weekly RAI...
Status
Unknown
Location
Fudan University Cancer Hospital
Start Date
2014-09
Trial ID
NCT02376452
Treatments Being Tested
This is a multi-center, open-label, randomized, phase 2, two-arm clinical t...
Status
Completed
Location
Multiple Locations
Start Date
2006-11-01
Trial ID
NCT00418938
Treatments Being Tested
The purpose of this study is to assess the anti-tumor activity of amivantam...
Status
Recruiting
Location
O Neal Comprehensive Cancer Center at UAB
Start Date
2022-07-29
Trial ID
NCT05379595
Treatments Being Tested